Release Date: 31/03/14 19:16 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 42.63KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%